SVA (Sinovac Biotech, Ltd) Stock Analysis - Analyst Ratings

Sinovac Biotech, Ltd (SVA) is a publicly traded the market company. As of May 20, 2026, SVA trades at $0.00 with a market cap of $0 and a P/E ratio of 0.00. SVA moved +0.00% today. Year to date, SVA is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces SVA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate SVA?

The average price target is $0.00.

SVA Key Metrics

Key financial metrics for SVA
MetricValue
Price$0.00
Market Cap$0
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$0.00
52-Week Low$0.00
Volume0
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

SVA Analyst Consensus

SVA analyst coverage data. Average price target: $0.00.

Common questions about SVA

What do analysts rate SVA?
The average price target is $0.00.
Does Rallies show SVA price targets?
Yes. Rallies tracks SVA analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is SVA research on Rallies investment advice?
No. Rallies provides research, data, and educational context for SVA. It does not provide personalized investment advice.
SVA

SVA